Mason Street Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-26,394
| Closed | -$548K | – | 325 |
|
|
2020
Q4 | $548K | Sell |
26,394
-58
| -0.2% | -$1.2K | 0.01% | 1140 |
|
|
2020
Q3 | $573K | Buy |
26,452
+4,125
| +18% | +$89.4K | 0.01% | 1047 |
|
|
2020
Q2 | $526K | Buy |
22,327
+1,748
| +8% | +$41.2K | 0.01% | 1063 |
|
|
2020
Q1 | $243K | Hold |
20,579
| – | – | 0.01% | 1219 |
|
|
2019
Q4 | $218K | Buy |
20,579
+654
| +3% | +$6.93K | ﹤0.01% | 1364 |
|
|
2019
Q3 | $227K | Buy |
19,925
+658
| +3% | +$7.5K | ﹤0.01% | 1341 |
|
|
2019
Q2 | $217K | Buy |
19,267
+1,696
| +10% | +$19.1K | ﹤0.01% | 1343 |
|
|
2019
Q1 | $142K | Buy |
17,571
+581
| +3% | +$4.7K | ﹤0.01% | 1474 |
|
|
2018
Q4 | $107K | Buy |
16,990
+804
| +5% | +$5.06K | ﹤0.01% | 1455 |
|
|
2018
Q3 | $159K | Buy |
16,186
+1,474
| +10% | +$14.5K | ﹤0.01% | 1427 |
|
|
2018
Q2 | $122K | Buy |
14,712
+661
| +5% | +$5.48K | ﹤0.01% | 1467 |
|
|
2018
Q1 | $101K | Buy |
14,051
+877
| +7% | +$6.3K | ﹤0.01% | 1468 |
|
|
2017
Q4 | $107K | Buy |
13,174
+398
| +3% | +$3.23K | ﹤0.01% | 1457 |
|
|
2017
Q3 | $185K | Buy |
12,776
+1,372
| +12% | +$19.9K | ﹤0.01% | 1342 |
|
|
2017
Q2 | $138K | Buy |
+11,404
| New | +$138K | ﹤0.01% | 1386 |
|